ARDT vs HCA vs NUTX Stock Comparison

Ardent Health, HCA Healthcare and Nutex Health Prices as of Nov 13, 2026 Peers: Industry group
ARDT Ardent Health, Inc.
$17.77 +48.7% 1M +91.1% 1Y
Market cap
$2.55B
P/E
17.4x
Revenue (TTM)
$6.45B
Div. yield
–
Hospitals Healthcare
1 win
HCA HCA Healthcare, Inc.
$499.31 +6.1% 1M +5.5% 1Y
Market cap
$109.68B
P/E
16.2x
Revenue (TTM)
$78.70B
Div. yield
–
Hospitals Healthcare
3 wins
NUTX Nutex Health Inc.
$173.67 -11.8% 1M +59.6% 1Y
Market cap
$1.17B
P/E
7.1x
Revenue (TTM)
$796.53M
Div. yield
0.07%
Hospitals Healthcare
6 wins

Head to Head

10 decided of 12

Nutex Health leads on 6 of the 12 questions below (Nutex Health 6, HCA Healthcare 3, Ardent Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionARDTHCANUTXLeader
Larger companyMarket capitalisation $2.55B $109.68B $1.17B HCA
Cheaper on earningsLower P/E, profitable companies only 17.4x 16.2x 7.1x NUTX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 17.3x 16.2x 6.2x NUTX
Faster revenue growthRevenue growth, trailing twelve months +2.0% +5.8% -18.8% HCA
More profitableNet margin, trailing twelve months 2.3% 8.6% 20.7% NUTX
Better return on capitalReturn on invested capital 9.5% 21.8% 43.9% NUTX
Less leveragedLower net debt / EBITDA 0.6x 3.1x -0.6x NUTX
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.07% –
Better 1-year returnPrice return, last 12 months +91.1% +5.5% +59.6% ARDT
Better 5-year returnAnnualised price return, 5 years — +15.3%/yr — –
Less volatileAnnualised volatility, 1 year 49.1% 32.7% 89.8% HCA
Higher overall scoreMean of the five percentile scores vs peers 65/100 58/100 81/100 NUTX

Percentile Scorecard

ARDTHCANUTX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisARDTHCANUTX
Valuation 96 #5 of 99 78 #23 of 99 92 #9 of 99
Growth 26 #66 of 89 24 #68 of 89 78 #20 of 89
Profitability 74 #25 of 92 96 #5 of 92 98 #3 of 92
Financial Health 63 #39 of 103 15 #88 of 103 87 #14 of 103
Shareholder Returns 65 #23 of 63 81 #13 of 63 52 #31 of 63
Overall 65 58 81
  • ARDT ranked among 103 companies in Healthcare Providers
  • HCA ranked among 103 companies in Healthcare Providers
  • NUTX ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodARDTHCANUTXSPY
1 month +48.7%+6.1%-11.8% -2.0%
3 months +62.7%+23.4%-7.3% -2.8%
6 months +75.9%+18.0%+37.5% +2.0%
Year to date +101.2%+7.0%+5.5% +10.6%
1 year +91.1%+5.5%+59.6% +12.2%
3 years —+110.2%+392.9% +68.1%
3 years, per year —+28.1%+70.2% +18.9%
5 years —+103.6%— +61.4%
5 years, per year —+15.3%— +10.1%
10 years —+617.6%— +248.5%
10 years, per year —+21.8%— +13.3%

Risk

MeasureARDTHCANUTXSPY
Volatility, 1Y 49.1%32.7%89.8% 13.6%
Downside volatility, 1Y 44.8%30.3%88.2% 13.9%
Beta vs S&P 500, 1Y 0.290.281.76 1.00
Return / volatility, 1Y 1.860.170.66 0.90
Max drawdown, 5Y -61.2%-39.7%-99.9% -25.4%
From 52-week high -2.3%-8.4%-22.8% -3.2%
52-week high $18.18$545.13$225.00 $779.14
52-week low $7.83$361.32$87.01 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleARDTHCANUTX
P/E now vs peer median 17.1xmedian 22.4x 15.8xmedian 22.4x 7.2xmedian 22.4x
P/S now vs peer median 0.4xmedian 1.3x 1.3xmedian 1.3x 1.5xmedian 1.3x
EV/EBITDA now vs peer median 5.5xmedian 14.2x 9.7xmedian 14.2x 2.9xmedian 14.2x
P/FCF now vs peer median 8.9xmedian 19.0x 17.6xmedian 19.0x 4.8xmedian 19.0x
P/B now vs peer median 1.4xmedian 2.6x -13.0xmedian 2.6x 2.2xmedian 2.6x
PEG now vs peer median —median 0.84 1.09median 0.84 0.07median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsARDTHCANUTX
Revenue $6.45B $78.70B $796.53M
Gross profit $5.35B $67.30B $380.67M
Operating income $343.67M $12.19B $311.00M
Net income $194.40M $7.80B $233.03M
Free cash flow $282.30M $5.97B $248.10M
EPS (diluted) $1.03 $31.20 $23.39
Cash & equivalents $766.24M $908.00M $249.91M
Total debt $1.10B $50.49B $42.37M
Shares (diluted) 141.70M 217.21M 7.04M
Enterprise value -$263.16M $104.04B $323.07M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricARDTHCANUTX
P/E 17.1x 15.8x 7.2x
P/FCF 8.9x 17.6x 4.8x
P/Operating cash flow 5.2x 9.4x 4.6x
P/S 0.4x 1.3x 1.5x
P/B 1.4x -13.0x 2.2x
P/Tangible book 1.5x -13.0x 2.3x
EV/EBITDA 5.5x 9.7x 2.9x
EV/EBIT 8.3x 12.7x 3.2x
EV/Revenue 0.4x 2.0x 1.2x
EV/FCF 10.0x 25.9x 3.9x
EV/Operating cash flow 5.9x 13.8x 3.8x
PEG (3Y EPS CAGR) – 1.09 0.07

Growth

14 metrics
MetricARDTHCANUTX
Revenue growth (1Y) 2.0% 5.8% -18.8%
Revenue CAGR (3Y) – 7.6% 50.9%
Gross profit growth (1Y) 1.7% 6.3% -29.5%
Gross profit CAGR (3Y) – 8.0% 158.3%
Operating income growth (1Y) -17.7% 6.0% -13.4%
Operating income CAGR (3Y) – 4.9% 208.2%
Net income growth (1Y) -16.1% 6.8% -11.6%
Net income CAGR (3Y) – 4.3% 121.3%
EPS growth (1Y) -28.9% 16.1% 46.8%
EPS CAGR (3Y) – 14.6% 96.4%
Operating cash flow growth (1Y) 31.4% -13.0% 45.4%
Operating cash flow CAGR (3Y) – 6.4% 224.9%
Free cash flow growth (1Y) 79.3% -26.2% 40.7%
Free cash flow CAGR (3Y) – 10.9% 237.1%

Profitability

14 metrics
MetricARDTHCANUTX
Gross margin 82.8% 85.5% 47.8%
EBITDA margin 8.0% 20.3% 41.8%
Operating margin 5.3% 15.5% 39.0%
Pretax margin 4.5% 12.5% 36.7%
Net margin 2.3% 8.6% 20.7%
FCF margin 4.4% 7.6% 31.1%
Operating cash flow margin 7.5% 14.2% 32.4%
Return on equity 13.1% – 44.5%
Return on assets 4.3% 12.3% 23.3%
Return on invested capital 9.5% 21.8% 43.9%
Return on capital employed 8.0% 28.0% 35.9%
Asset turnover 1.2x 1.2x 0.8x
Cash conversion (OCF / net income) 2.5x 1.4x 1.1x
Stock comp / revenue 0.5% 0.5% 0.5%

Financial Health

11 metrics
MetricARDTHCANUTX
Debt / assets 20.5% 79.6% 4.1%
Debt / equity 0.6x -6.3x 0.1x
Net debt / EBITDA 0.6x 3.1x -0.6x
Debt / FCF 3.9x 8.5x 0.2x
Liabilities / assets 66.6% 112.7% 47.6%
Equity / assets 33.4% -12.7% 52.4%
Interest coverage 6.5x 5.2x 16.2x
Current ratio 2.1x 0.8x 4.8x
Quick ratio 1.4x 0.7x 4.7x
Cash ratio 0.8x 0.1x 1.9x
Altman Z-score 2.26 2.52 3.62

Shareholder Returns

7 metrics
MetricARDTHCANUTX
Dividend yield – 0.6% –
Net buyback yield 0.4% 8.7% -0.2%
Shareholder yield 0.4% 9.3% -0.2%
Payout ratio (earnings) – – 36.8%
Payout ratio (FCF) – – 34.6%
Dividend growth (1Y) – – 90.9%
Dividend CAGR (3Y) – – 148.5%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusARDTHCANUTX
Forward P/E 17.3xFY2026 16.2xFY2026 6.2xFY2026
EPS, next fiscal year $1.03FY2026 $30.83FY2026 $28.17FY2026
EPS growth, next FY +7.3%FY2026 +9.3%FY2026 +168.8%FY2026
EPS growth, the year after +12.6% +6.2% -7.0%
Revenue, next fiscal year $6.86BFY2026 $73.66BFY2026 $824.69MFY2026
Revenue growth, next FY +8.5%FY2026 -2.6%FY2026 -5.8%FY2026
Revenue growth, the year after +0.4% +18.0% +19.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersARDTHCANUTX
Held by institutions 76.4% 59.5% 42.8%
Institutions holding 137 1,339 154
Change in shares held, QoQ +1.4% +0.3% +5.8%
Institutions buying 87 569 100
Institutions selling 36 565 36
Buyers to sellers 2.42 1.01 2.78

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ARDTHCANUTX
ARDT 1.00 0.41 0.08
HCA 0.41 1.00 0.08
NUTX 0.08 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ARDT, HCA and NUTX?

HCA Healthcare (HCA) is the largest by market capitalisation: Ardent Health (ARDT) $2.55B, HCA Healthcare (HCA) $109.68B, Nutex Health (NUTX) $1.17B.

Which stock is cheaper, ARDT, HCA and NUTX?

Nutex Health (NUTX) trades on the lowest price-to-earnings ratio (Ardent Health (ARDT) 17.4x, HCA Healthcare (HCA) 16.2x, Nutex Health (NUTX) 7.1x). On next year's consensus earnings, Nutex Health (NUTX) is cheapest (Ardent Health (ARDT) 17.3x, HCA Healthcare (HCA) 16.2x, Nutex Health (NUTX) 6.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

HCA Healthcare (HCA) grew revenue fastest over the trailing twelve months: Ardent Health (ARDT) +2.0%, HCA Healthcare (HCA) +5.8%, Nutex Health (NUTX) -18.8%.

Which company is more profitable?

Nutex Health (NUTX) has the highest net margin (Ardent Health (ARDT) 2.3%, HCA Healthcare (HCA) 8.6%, Nutex Health (NUTX) 20.7%). On return on invested capital, Nutex Health (NUTX) leads (Ardent Health (ARDT) 9.5%, HCA Healthcare (HCA) 21.8%, Nutex Health (NUTX) 43.9%).

Which stock has performed better?

Over the past year Ardent Health (ARDT) returned the most: Ardent Health (ARDT) +91.1%, HCA Healthcare (HCA) +5.5%, Nutex Health (NUTX) +59.6%. Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Ardent Health (ARDT) 0.00%, HCA Healthcare (HCA) 0.00%, Nutex Health (NUTX) 0.07%. Ardent Health (ARDT) and HCA Healthcare (HCA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, HCA Healthcare (HCA) has been the steadiest (Ardent Health (ARDT) 49.1%, HCA Healthcare (HCA) 32.7%, Nutex Health (NUTX) 89.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ARDT, HCA and NUTX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Nutex Health (NUTX) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.